Memorial Sloan Kettering Cancer Center: Cholangiocarcinoma trials

The registry lists 11 Cholangiocarcinoma studies with Memorial Sloan Kettering Cancer Center as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 6No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryRecruitingNCT04891289Phase 2
• Trial of IRE in CholangiocarcinomaCompletedNCT03769753Phase 2Results posted
• A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or CholangiocarcinomaCompletedNCT03693807Phase 2Results posted
• Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)CompletedNCT01862315Phase 2Results posted
• Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic TherapyCompletedNCT00919061Phase 2Results posted
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic CholangiocarcinomaCompletedNCT01938729Phase 1
• Clinical and Histopathologic Characteristics of BAP1 MutationsCompletedNCT01773655
• Anonymous Testing of Pathology Specimens for BRCA Mutations in Ashkenazi Jewish Individuals Who Have CancerWithdrawnNCT00588263
• Quality Of Life in Patients With Malignant Biliary ObstructionCompletedNCT00579865
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or PancreasCompletedNCT00003923Phase 2
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal CancerCompletedNCT00003427Phase 1